Updated hourlyHourly refreshFri, Oct 30, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance
WATERLOO, ON, Sept. 30, 2026 -- Open Text Corporation ("OpenText" or the "Company") (NASDAQ: OTEX), (TSX: OTEX) today announced the pricing terms and results of its previously announced tender offer (the "Tender Offer") to purchase for cash up to $300,000,000 aggregate...
Sep 30 · 22:40·PR Newswire
Finance
CALGARY, Alberta, Sept. 30, 2026 -- Pulse Seismic Inc. (TSX:PSD) (OTCQX:PLSDF) (“Pulse” or the “Company”) today announced preliminary third quarter 2026 revenue results. The Company expects to issue and file its financial results for the three and nine months ended September 30, 2026 on SEDAR+ (www.sedarplus.ca) and will make them available on Pulse’s website at www.pulseseismic.com after markets close on October 21, 2026.
Sep 30 · 22:30·GlobeNewswire
Finance · Travel
MIAMI, Sept. 30, 2026 -- NCL Corporation Ltd. (“NCLC”), a subsidiary of Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (“NCLH”), announced today that it has priced $950.0 million aggregate principal amount of its 8.750% senior notes due 2031 (the “Notes”), which were offered in a private offering (the “Offering”) that is exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”). The aggregate principal amount of Notes to be issued was increased to $950.0 million from the previously announced $750.0 million.
Sep 30 · 22:12·GlobeNewswire
Finance
Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide), today announced detailed results from the Phase 3 ACHIEVE-4 trial evaluating...
Sep 30 · 22:00·Eli Lilly and Company
Finance
Tórshavn, Faroe Islands, 2026-09-30 -- Today P/F Atlantic Petroleum (Nasdaq Copenhagen: ATLA DKK) has submitted an Application for an Exploration and Production Licence in the Faroe Islands under the Open Door Licensing Regime.
Sep 30 · 21:49·GlobeNewswire
Finance · Biotech & pharma
GLEN ALLEN, Va., Sept. 30, 2026 -- Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that the Company’s Compensation Committee has granted a new employee stock option to purchase 155,446 shares of common stock as an inducement to such person becoming an employee of the Company.
Sep 30 · 21:46·GlobeNewswire
Finance
ORINDA, Calif., Sept. 30, 2026 -- MacKenzie Realty Capital, Inc. (Nasdaq: MKZR) (“MacKenzie” or the “Company”) today announced its financial results for the year ended June 30, 2026 and announced that its Board has temporarily suspended the Preferred Share Repurchase Program while it explores strategic transactions such as reverse takeovers.
Sep 30 · 21:46·GlobeNewswire
Finance
TORONTO, Sept. 30, 2026 -- Xanadu Quantum Technologies Limited (“Xanadu”; NASDAQ/TSX: XNDU), a leading photonic quantum computing company, today announced that Rafal Janik, Xanadu's Chief Operating Officer, has entered into an automatic securities disposition plan (the “Plan”) to sell Class B Subordinate Voting Shares of Xanadu ("Class B Shares") held directly by Mr. Janik. The Plan has been adopted in accordance with applicable securities laws and Xanadu’s internal policies. Sales of Class B Shares under the Plan are eligible to commence on or after December 29, 2026.
Sep 30 · 21:40·GlobeNewswire
Finance · Healthcare
NEW YORK, Sept. 30, 2026 -- Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) (“Bright Minds” or the “Company”), a clinical stage biotechnology company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, Prader-Willi Syndrome, depression, and other central nervous system (CNS) disorders, today announced that it will participate in the Foundation for Prader-Willi Research (FPWR) 2026 Research Symposium, October 7-8, and the PWS Family Conference, October 9-10, at the Marriott Philadelphia Downtown.
Sep 30 · 21:30·GlobeNewswire
Finance
MEXICO CITY, Sept. 30, 2026 -- Grupo Aeroméxico S.A.B. de C.V. (NYSE: AERO & BMV: AERO) (“Aeroméxico”) will hold a live conference call and webcast on Tuesday, October 20, 2026, at 8:00 a.m. Mexico City Time (10:00 a.m. Eastern Time) to discuss its third quarter 2026 financial results.
Sep 30 · 21:30·GlobeNewswire
Finance · Biotech & pharma
– Financing includes leading U.S. biotechnology institutional investors and mutual funds –
– Financing includes leading U.S. biotechnology institutional investors and mutual funds –
Sep 30 · 21:15·GlobeNewswire
Finance
NEW YORK, Sept. 30, 2026 --
WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) resulting from allegations that Ensign may have issued materially misleading business information to the investing public.
Sep 30 · 21:12·GlobeNewswire